CAS 72496-41-4: Pirarubicina

Descrizione: Pirarubicina, con il numero CAS 72496-41-4, è un antibiotico antraciclino che viene utilizzato principalmente come agente antineoplastico nella terapia del cancro. È strutturalmente correlato alla doxorubicina e presenta meccanismi d'azione simili, principalmente intercalandosi nel DNA, inibendo così la sintesi di DNA e RNA, il che porta alla morte cellulare. Pirarubicina è particolarmente efficace contro vari tipi di cancro, inclusi il cancro al seno e la leucemia. Il suo profilo farmacologico include un livello di citotossicità moderato-alto e viene spesso somministrato per via endovenosa. Il farmaco è noto per i suoi potenziali effetti collaterali, che possono includere cardiotossicità, mielosoppressione e disturbi gastrointestinali. A causa della sua struttura chimica, Pirarubicina può anche generare specie reattive dell'ossigeno, contribuendo ai suoi effetti anticancro. Il composto è tipicamente utilizzato in combinazione con altri agenti chemioterapici per migliorare l'efficacia terapeutica mentre si gestisce la resistenza. Come con tutti gli agenti chemioterapici, un attento monitoraggio dei pazienti è essenziale per mitigare gli effetti avversi e ottimizzare i risultati del trattamento.

Formula: C₃₂H₃₇NO₁₂

InChI: InChI=1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21+,22-,31+,32-/m0/s1

InChI key: InChIKey=KMSKQZKKOZQFFG-YXRRJAAWSA-N

SMILES: O=C1C=2C=CC=C(OC)C2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(C(=O)CO)CC4OC5OC(C)C(OC6OCCCC6)C(N)C5

Sinonimi:

• (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2S)-tetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranoside
• (2''R)-4'-O-Tetrahydropyranyladriamycin
• (2′′R)-4′-O-Tetrahydropyranyladriamycin
• (2′′R)-4′-O-Tetrahydropyranyldoxorubicin
• (3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranoside
• (8S,10S)-10-((3-Amino-2,3,6-trideoxy-4-O-(2R-tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
• (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
• 1609Rb
• 4'-O-Tetrahydropyranyladriamycin
• 4'-O-Tetrahydropyranyldoxorubicin
• 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, [8S-[8α,10α(S*)]]-
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
• Pinorubicin
• Pirarubicin Hydrochloride
• Pirarubicin [INN:JAN]
• Pirarubicina
• Pirarubicina [Spanish]
• Pirarubicine
• Pirarubicine [French]
• Pirarubicinum
• Pirarubicinum [Latin]
• THP-adriamycin
• Therarubicin
• (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-
• 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, [8S-[8α,10α(S*)]]-

Pirarubicin

CAS: 72496-41-4

• Formula: C₃₂H₃₇NO₁₂
• Purezza: 98%
• Colore e forma: Solid
• Peso molecolare: 627.6356800000001

Pirarubicin

CAS: 72496-41-4

• Purezza: ≥98%
• Peso molecolare: 627.64g/mol

(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-6-Methyl-5-(((R)-Tetrahydro-2H-Pyran-2-Yl)Oxy)Tetrahydro-2H-Pyran-2-Yl)Oxy)-6,8,11-Trihydroxy-8-(2-Hydroxyacetyl)-1-Methoxy-7,8,9,10-Tetrahydrotetracene-5,12-Dione

CAS: 72496-41-4

• Purezza: 98%
• Peso molecolare: 627.64g/mol

Pirarubicin

CAS: 72496-41-4

Pirarubicin (Theprubicin), an anthracycline antibiotic, inhibits DNA/RNA synthesis and is used as an antineoplastic.

• Formula: C₃₂H₃₇NO₁₂
• Purezza: 97.61% - 98.27%
• Colore e forma: Red Crystalline Powder
• Peso molecolare: 627.64

Pirarubicin

CAS: 72496-41-4

• Formula: C₃₂H₃₇NO₁₂
• Purezza: ≥ 95%
• Colore e forma: Red to orange powder
• Peso molecolare: 627.64

Pirarubicin

CAS: 72496-41-4

Antibiotic of anthracycline class; DNA synthesis inhibitor

• Formula: C₃₂H₃₇NO₁₂
• Purezza: Min. 95%
• Colore e forma: Powder
• Peso molecolare: 627.64 g/mol

Pirarubicin

CAS: 72496-41-4

Applications Structural analog of Doxorubicin. Antineoplastic. References Umezawa, H., et al.: J. Antibiot., 32, 1082 …

• Formula: C₃₂H₃₇NO₁₂
• Colore e forma: Neat
• Peso molecolare: 627.64